Roadside Drug Testing Devices Market Forecast, 2019 - 2027

Roadside Drug Testing Devices Market (Substance: Drugs [Tetrahydrocannabinol {THC}, Cocaine, Amphetamine, Benzodiazepines, Opioids, and Others] and Alcohol; Sample Type: Saliva, Sweat, Urine, and Others; and Modality: Handheld and Standalone) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Novel Roadside Handheld Devices Offer Convenience of Drug Detection

An alarming rate of deaths caused due to drink and drive scenarios are increasingly becoming a matter of concern for government authorities worldwide. Thus, innovations in the healthcare industry are generating incremental opportunities for companies in the roadside drug testing devices market. For instance, in December 2019, Abbott-a global leader in medical devices announced the launch of the SoToxa™ Mobile Test System, which is acquiring global recognition. Novel roadside drug testing devices are gaining importance to combat drug-impaired driving and ensure road safety.

Companies in the roadside drug testing devices market are increasing their production capabilities to develop handheld devices. This is evident since handheld modality segment is estimated for exponential growth during the forecast period and the global roadside drug testing devices market is expected to reach a value of ~US$ 924 Mn by the end of 2027. Stakeholders in law enforcement are using oral fluid swabs that are inserted in handheld analyzers to detect marijuana and other drugs within minutes.

roadside drug testing devices market infographic

Driving Simulators Help in Conducting Successful Clinical Trials

As suggested by the Swinburne University of Technology, drug users are apparently surpassing the number of alcohol consumers in Australia, resulting in high rates of fatal crashes. Hence, companies in the roadside drug testing devices market should tap opportunities in Australia to increase the uptake of detection devices. Likewise, companies in the market for roadside drug testing devices are collaborating with researchers to increase R&D in psychology and neurosciences to ascertain if drivers under the influence of cannabis are more likely to meet with an accident, as compared to alcohol consumers.

With the introduction of driving simulators, companies in the roadside drug testing devices market are able to conduct better analysis of cognitive behavior and psychomotor functioning of individuals through the help of clinical trials. Companies in the market for roadside drug testing devices are gaining important insights through research findings carried out as a result of collaborations between universities and medical institutes.

Breathalyzers with Nanotechnology Sensors a Gold Standard for Detection of THC

Breathalyzers are becoming increasingly mainstream in the detection of alcohol in the roadside drug testing devices market. However, there is a growing need for breathalyzers that are also capable of detecting marijuana. Hence, researchers in the market for roadside drug testing devices are increasing R&D to develop novel breathalyzers that detect THC. For instance, an interdisciplinary team at the University of Pittsburgh, developed a breathalyzer using nanotechnology sensors that detect THC. Thus, innovative breathalyzers are increasingly becoming the gold standard for THC detection and manufacturers should collaborate with researchers to innovate in devices. This trend has supported the exponential growth of THC among other substance types in the roadside drug testing devices market.

Companies in the roadside drug testing devices market are increasing research in developing breathalyzers using carbon nanotubes and nanotechnology sensors to meet requirements of mass spectrometry. This trend is prominent in the U.S. since legalization of recreational marijuana has raised concerns about the enforcement of DUI (Driving Under the Influence) laws in the region.

Innovations in THC Breathalyzers Generate Incremental Opportunities for Manufacturers

Since THC drugs segment is anticipated for exponential growth in the market for roadside drug testing devices, manufacturers are introducing breakthrough innovations that are a novel addition to the cannabis detection sector. For instance, Cannabix Technologies- a supplier of drug detection tools has announced that its scientific team has come up with a proprietary method-Field asymmetric waveform ion mobility spectrometry (FAIMS) to detect THC. Such innovations have contributed toward the modest of the roadside drug testing devices market, which is expected to expand at a CAGR of ~4% during the forecast period. Hence, manufacturers are focusing on innovating breathalyzers using high-field ion mobility and mass spectrometry.

Companies in the roadside drug testing devices market are developing lightweight devices that are user-friendly and store numerous samples. They are increasing efforts to develop devices that are capable of detecting extremely low quantities of THC analytes. Thus, innovative breathalyzers are increasingly replacing conventional breath analyzing techniques. 

roadside drug testing devices market segmentation

Analysts’ Viewpoint

The roadside drug testing devices market is projected for exponential growth in North America. Lack of efficient DUI laws in the U.S. are fueling the demand for drug testing devices. Manufacturers are increasing efforts to meet the demand for breath analyzers that can detect extremely low quantities of THC analytes.

Increased research spending has become the key focus point of companies in the market landscape. However, incidences of false positives from poppy seeds and tea in drug testing devices act as barriers for market growth. Hence, manufacturers should develop devices that can differentiate between drugs or alcohol and food items that are merely in the system of an individual.

Roadside Drug Testing Devices Market: Overview

  • According to Transparency Market Research’s latest research report on the global roadside drug testing devices market for the historical period of 2017–2018 and the forecast period of 2019–2027, increase in the number of drug and alcohol abusers and adoption of rapid test devices for screening or identification of drug and alcohol are anticipated to drive the global roadside drug testing devices market during the forecast period
  • According to the report, the global roadside drug testing devices market was valued at US$ 0.65 Bn in 2018. It is projected to expand at a CAGR of ~4% from 2019 to 2027.

Technological Advancements in Roadside Drug Testing Devices to Propel Market: A Key Driver

  • Roadside drug testing devices have already been adopted by the police force, with the introduction of a large number of new breathalyzer devices
  • Recent advancements by providers of drug, alcohol, and disease-testing products offer police with a robust set of roadside testing tools for the detection of alcohol and drug classes such as amphetamine, benzodiazepines, cannabis (THC), cocaine, methamphetamine, and opiates
  • New tests, such as paper spray mass spectrometry, analyze molecules in a fingerprint. As the body metabolizes a drug, it excretes molecules, which can (apparently) be detected in fingerprints by using the mass spectrometry method. The method works even after the hands are washed. Hence, there is no ‘coming clean’ with a quick trip to the sink. Researchers report 99% of accuracy rate by using this method.
  • Increase in the burden of drug and alcohol abuse and technological advancements have resulted in the adoption of portable roadside drug testing devices. Thus, rise in the demand for portable or handheld roadside drug testing devices is expected to propel the global roadside drug testing devices market during the forecast period.

Large Target Population

  • Increase in the number of drug and alcohol abusers across the world is expected to provide significant opportunities to test providers and manufacturers of drug abuse test products in the near future. According to the United Nations Office of Drug and Crime, over 5% of the global population aged between 15 and 64 years uses illicit drugs. Moreover, nearly 32.4 million people worldwide use pharmaceutical opioids and opiates such as opium or heroin.
  • According to the Centers for Disease Control and Prevention (CDC), around 4.7% of people aged 16 years or above in the U.S. are reported to be driving under the influence of marijuana and 0.9% are reported to be driving under the influence of illicit drugs other than marijuana.
  • Rise in target population and increase in government initiatives to control road accidents and fatalities in various countries are likely to drive the global roadside drug testing devices market during the forecast period

Inaccurate Results to Hamper Roadside Drug Testing Devices Market

  • Concerns about the efficacy and efficiency of roadside drug testing devices have increased over the last few years. For instance, in a study, which included over 300 Norway-based drivers who were tested for impairment by using both the oral device as well as the blood sample, it was found that the ratio of false-positive results generated by the device to findings of the blood sample was 14.5% for cannabis and 87.1% for cocaine.
  • Inaccurate results (false-positive or false-negative results) associated with roadside drug testing devices are projected to restrain the global roadside drug testing devices market during the forecast period

Roadside Drug Testing Devices Market: Competition Landscape

  • This report profiles major players operating in the global roadside drug testing devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The roadside drug testing devices market is moderately fragmented with the presence of a few large-scale players in the global market and some small-scale players in regional markets. The top four to five players hold a major share of the global roadside drug testing devices market.
  • Prominent players operating in the global roadside drug testing devices market are 
    • Drägerwerk AG & Co. KgaA
    • Abbott Laboratories
    • Oranoxis Inc.
    • CareHealth America
    • MAVAND Solutions GmbH
    • Pacific Data Systems Pty Ltd
    • Securetec, and UriTox, LLC

Roadside Drug Testing Devices Market: Key Developments

  • Key players operating in the global roadside drug testing devices market are engaged in the development and approval of new products, mergers and acquisitions, and collaborations. Major developments by key players operating in the global market are likely to fuel the global roadside drug testing devices market in the next few years. Some of the key developments in the global roadside drug testing devices market are as follows:
    • In October 2017, Abbott Laboratories acquired Alere, Inc. for approximately US$ 4.5 Bn. The acquisition strengthened the company’s product portfolio in the point of care testing devices and solutions segment. SoToxa, formerly known as the Alere DDS2 mobile test system, is able to generate test results indicating the presence of certain drugs in just five minutes. SoToxa is currently being used by law enforcement agencies in countries across the world including Canada, Germany, Spain, the U.K., and the U.S.
    • In September 2018, Securetec launched WipeAlyser, a mobile analysis device for use with the DrugWipe rapid drug screening test. DrugWipe itself is a highly precise saliva test for quick and safe detection of up to seven drug types.
    • In June 2019, Securetec developed the DrugWipe 2S saliva test for buprenorphine and methadone. The two active substances i.e. buprenorphine and methadone were used successfully to treat drug addiction.
  • The report on the global roadside drug testing devices market discusses individual strategies, followed by company profiles of manufacturers of roadside drug testing devices. The ‘Competition Landscape’ section has been included in the report to provide readers with a dashboard view and company market share analysis of key players operating in the global roadside drug testing devices market.

Roadside Drug Testing Devices Market – Segmentation

Substance

Drugs

  • Tetrahydrocannabinol (THC)
  • Cocaine
  • Amphetamine
  • Benzodiazepines
  • Opioids
  • Others

Alcohol

Sample Type

Saliva

Sweat

Urine

Others

Modality

Handheld

Standalone

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of roadside drug testing devices market?

Roadside drug testing devices market is expected to reach a value of ~US$ 924 Mn by the end of 2027

What is the anticipated CAGR of the roadside drug testing devices market in the forecast period?

Roadside drug testing devices market is projected to expand at a CAGR of ~4% from 2019 to 2027

What are the key driving factors for the growth of the roadside drug testing devices market?

Roadside drug testing devices market is driven by increase in the number of drug and alcohol abusers

Which region is expected to project the highest market share in the global roadside drug testing devices market?

North America accounted for a major share of the global roadside drug testing devices market

Who are the key players in the roadside drug testing devices market?

Key players in the global roadside drug testing devices market are Drägerwerk AG & Co. KgaA, Abbott Laboratories, Oranoxis, Inc., CareHealth America

    1. Preface

       1.1. Market Definition and Scope

       1.2. Market Segmentation

       1.3. Key Research Objectives

       1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Roadside Drug Testing Devices Market 

    4. Market Overview

       4.1. Introduction

           4.1.1.  Pricing Analysis

           4.1.2.  Industry Evolution/ Developments

       4.2. Overview

       4.3. Market Dynamics

           4.3.1. Drivers

           4.3.2. Restraints

       4.4. Global Roadside Drug Testing Devices Market Analysis and Forecast, 2017–2027

    5. Market Outlook

       5.1. Technological Advancements 

       5.2. Roadside Drugs Testing Programs, by Country/Region

       5.3. Regulatory Scenario Assessment

       5.4. Key Industry Events (mergers, acquisitions, collaborations, launch & approvals, etc.)

    6. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Modality 

       6.1. Introduction & Definition

       6.2. Key Findings / Developments

       6.3. Market Value Forecast, by Modality, 2017–2027

           6.3.1.  Handheld

           6.3.2. Standalone

       6.4. Market Attractiveness Analysis, by Modality 

    7. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Substance 

       7.1. Introduction & Definition

       7.2. Key Findings / Developments

       7.3. Market Value Forecast, by Substance, 2017–2027

           7.3.1.  Drugs

               7.3.1.1. Tetrahydrocannabinol (THC)

               7.3.1.2. Cocaine

               7.3.1.3. Amphetamine

               7.3.1.4. Benzodiazepines

               7.3.1.5. Opioids

               7.3.1.6. Others

           7.3.2.  Alcohol

       7.4. Market Attractiveness Analysis, by Substance 

    8. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Sample Type

       8.1. Introduction & Definition

       8.2. Key Findings / Developments

       8.3. Market Value Forecast, by Sample Type, 2017–2027

           8.3.1.  Saliva

           8.3.2. Sweat

           8.3.3. Urine

           8.3.4. Others

       8.4. Market Attractiveness Analysis, by Substance 

    9. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Region

       9.1. Key Findings / Developments

       9.2. Market Value Forecast, by Region, 2017–2027

           9.2.1.  North America

           9.2.2. Europe

           9.2.3. Asia Pacific

           9.2.4. Latin America

           9.2.5. Middle East & Africa

       9.3. Market Attractiveness Analysis, by Region

    10. North America Roadside Drug Testing Devices Market Analysis and Forecast

       10.1. Key Findings

       10.2. Market Value Forecast, by Modality, 2017–2027

           10.2.1.  Handheld

           10.2.2. Standalone

       10.3. Market Value Forecast, by Substance, 2017–2027

           10.3.1. Drugs

               10.3.1.1. Tetrahydrocannabinol (THC)

               10.3.1.2. Cocaine

               10.3.1.3. Amphetamine

               10.3.1.4. Benzodiazepines

               10.3.1.5. Opioids

               10.3.1.6. Others

           10.3.2. Alcohol

       10.4. Market Value Forecast, by Sample Type, 2017–2027

           10.4.1. Saliva

           10.4.2. Sweat

           10.4.3. Urine

           10.4.4. Others

       10.5. Market Attractiveness Analysis, by Country, 2017–2027

           10.5.1. U.S.

           10.5.2. Canada

       10.6. Market Attractiveness Analysis 

           10.6.1. By Modality 

           10.6.2. By Substance 

           10.6.3. By Sample Type 

           10.6.4. By Country

    11. Europe Roadside Drug Testing Devices Market Analysis and Forecast

       11.1. Key Findings

       11.2. Market Value Forecast, by Modality, 2017–2027

           11.2.1.  Handheld

           11.2.2. Standalone

       11.3. Market Value Forecast, by Substance, 2017–2027

           11.3.1. Drugs

               11.3.1.1. Tetrahydrocannabinol (THC)

               11.3.1.2. Cocaine

               11.3.1.3. Amphetamine

               11.3.1.4. Benzodiazepines

               11.3.1.5. Opioids

               11.3.1.6. Others

           11.3.2. Alcohol

       11.4. Market Value Forecast, by Sample Type, 2017–2027

           11.4.1. Saliva

           11.4.2. Sweat

           11.4.3. Urine

           11.4.4. Others

       11.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

           11.5.1. Germany

           11.5.2. U.K.

           11.5.3. France

           11.5.4. Italy

           11.5.5. Spain

           11.5.6. Rest of Europe

       11.6. Market Attractiveness Analysis 

           11.6.1. By Modality 

           11.6.2. By Substance 

           11.6.3. By Sample Type 

           11.6.4. By Country/Sub-region

    12. Asia Pacific Roadside Drug Testing Devices Market Analysis and Forecast

       12.1. Key Findings

       12.2. Market Value Forecast, by Modality, 2017–2027

           12.2.1.  Handheld

           12.2.2. Standalone

       12.3. Market Value Forecast, by Substance, 2017–2027

           12.3.1. Drugs

               12.3.1.1. Tetrahydrocannabinol (THC)

               12.3.1.2. Cocaine

               12.3.1.3. Amphetamine

               12.3.1.4. Benzodiazepines

               12.3.1.5. Opioids

               12.3.1.6. Others

           12.3.2. Alcohol

       12.4. Market Value Forecast, by Sample Type, 2017–2027

           12.4.1. Saliva

           12.4.2. Sweat

           12.4.3. Urine

           12.4.4. Others

       12.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

           12.5.1. China

           12.5.2. Japan

           12.5.3. India

           12.5.4. Australia & New Zealand

           12.5.5. Rest of Asia Pacific

       12.6. Market Attractiveness Analysis 

           12.6.1. By Modality 

           12.6.2. By Substance 

           12.6.3. By Sample Type 

           12.6.4. By Country/Sub-region

    13. Latin America Roadside Drug Testing Devices Market Analysis and Forecast

       13.1. Key Findings

       13.2. Market Value Forecast, by Modality, 2017–2027

           13.2.1.  Handheld

           13.2.2. Standalone

       13.3. Market Value Forecast, by Substance, 2017–2027

           13.3.1. Drugs

               13.3.1.1. Tetrahydrocannabinol (THC)

               13.3.1.2. Cocaine

               13.3.1.3. Amphetamine

               13.3.1.4. Benzodiazepines

               13.3.1.5. Opioids

               13.3.1.6. Others

           13.3.2. Alcohol

       13.4. Market Value Forecast, by Sample Type, 2017–2027

           13.4.1. Saliva

           13.4.2. Sweat

           13.4.3. Urine

           13.4.4. Others

       13.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

           13.5.1. Brazil

           13.5.2. Mexico

           13.5.3. Rest of Latin America

       13.6. Market Attractiveness Analysis 

           13.6.1. By Substance 

           13.6.2. By Substance 

           13.6.3. By Sample Type 

           13.6.4. By Country/Sub-region

    14. Middle East & Africa Roadside Drug Testing Devices Market Analysis and Forecast

       14.1. Key Findings

       14.2. Market Value Forecast, by Modality, 2017–2027

           14.2.1.  Handheld

           14.2.2. Standalone

       14.3. Market Value Forecast, by Substance, 2017–2027

           14.3.1. Drugs

               14.3.1.1. Tetrahydrocannabinol (THC)

               14.3.1.2. Cocaine

               14.3.1.3. Amphetamine

               14.3.1.4. Benzodiazepines

               14.3.1.5. Opioids

               14.3.1.6. Others

           14.3.2. Alcohol

       14.4. Market Value Forecast, by Sample Type, 2017–2027

           14.4.1. Saliva

           14.4.2. Sweat

           14.4.3. Urine

           14.4.4. Others

       14.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027

           14.5.1. GCC Countries

           14.5.2. South Africa

           14.5.3. Rest of Middle East & Africa

       14.6. Market Attractiveness Analysis

           14.6.1. By Modality 

           14.6.2. By Substance 

           14.6.3. By Sample Type 

           14.6.4. By Country/Sub-region

    15. Competition Landscape

       15.1. Market Player - Competition Matrix (By Tier and Size of companies)

       15.2. Market Share Analysis, by Company, 2018

       15.3. Company Profiles

           15.3.1. Abbott 

               15.3.1.1. Company Overview

               15.3.1.2. Company Financials

               15.3.1.3. Growth Strategies

               15.3.1.4. SWOT Analysis

           15.3.2. Drägerwerk AG & Co. KGaA. 

               15.3.2.1. Company Overview

               15.3.2.2. Company Financials

               15.3.2.3. Growth Strategies

               15.3.2.4. SWOT Analysis

           15.3.3. UriTox, LLC

               15.3.3.1. Company Overview

               15.3.3.2. Growth Strategies

               15.3.3.3. SWOT Analysis

           15.3.4. Oranoxis, Inc.

               15.3.4.1. Company Overview

               15.3.4.2. Growth Strategies

               15.3.4.3. SWOT Analysis

           15.3.5. Securetec

               15.3.5.1. Company Overview

               15.3.5.2. Growth Strategies

               15.3.5.3. SWOT Analysis

           15.3.6. CareHealth America

               15.3.6.1. Company Overview

               15.3.6.2. Growth Strategies

               15.3.6.3. SWOT Analysis

           15.3.7. MAVAND Solutions GmbH

               15.3.7.1. Company Overview

               15.3.7.2. Growth Strategies

               15.3.7.3. SWOT Analysis

           15.3.8. Pacific Data Systems Pty Ltd.

               15.3.8.1. Company Overview

               15.3.8.2. Growth Strategies

               15.3.8.3. SWOT Analysis

    List of Tables

    Table 01: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

    Table 02: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 03: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

    Table 04: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

    Table 05: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 06: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

    Table 07: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 08: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

    Table 09: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

    Table 10: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 11: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

    Table 12: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 13: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

    Table 14: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

    Table 15: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 16: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

    Table 17: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 18: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

    Table 19: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

    Table 20: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 21: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

    Table 22: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 23: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

    Table 24: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

    Table 25: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 26: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027

    Table 27: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

    Table 28: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027

    Table 29: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027

    Table 30: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    List of Figures

    Figure 01: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, 2017–2027

    Figure 02: Global Roadside Drug Testing Devices Market Value Share, by Substance, 2018

    Figure 03: Global Roadside Drug Testing Devices Market Value Share, by Sample Type, 2018

    Figure 04: Global Roadside Drug Testing Devices Market Value Share, by Modality, 2018

    Figure 05: Global Roadside Drug Testing Devices Market Value Share, by Region, 2018

    Figure 06: Global Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

    Figure 07: Global Roadside Drug Testing Devices Market Value Share Analysis, by Drugs, 2018 and 2027

    Figure 08: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Drugs, 2019–2027

    Figure 09: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs,

    Figure 10: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Alcohol, 2017–2027

    Figure 11: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tetrahydrocannabinol (THC), 2017–2027

    Figure 12: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cocaine, 2017–2027

    Figure 13: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Amphetamine, 2017–2027

    Figure 14: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Benzodiazepines, 2017–2027

    Figure 15: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Opioids, 2017–2027

    Figure 16: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 17: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

    Figure 18: Global Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

    Figure 19: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Saliva, 2017–2027

    Figure 20: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 21: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urine, 2017–2027

    Figure 22: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Sweat, 2017–2027

    Figure 23: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

    Figure 24: Global Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

    Figure 25: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Handheld, 2017–2027

    Figure 26: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Standalone, 2017–2027

    Figure 27: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

    Figure 28: Global Roadside Drug Testing Devices Market Value Share Analysis, by Region, 2018 and 2027

    Figure 29: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Region, 2019–2027

    Figure 30: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 31: North America Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

    Figure 32: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

    Figure 33: North America Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

    Figure 34: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

    Figure 35: North America Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

    Figure 36: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

    Figure 37: North America Roadside Drug Testing Devices Market Value Share Analysis, by Country, 2018 and 2027

    Figure 38: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Country, 2019–2027

    Figure 39: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 40: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

    Figure 41: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

    Figure 42: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

    Figure 43: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

    Figure 44: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

    Figure 45: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

    Figure 46: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 47: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 48: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 49: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

    Figure 50: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

    Figure 51: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

    Figure 52: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

    Figure 53: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

    Figure 54: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

    Figure 55: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 56: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 57: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 58: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

    Figure 59: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

    Figure 60: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

    Figure 61: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

    Figure 62: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

    Figure 63: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

    Figure 64: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 65: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 66: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 67: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027

    Figure 68: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027

    Figure 69: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027

    Figure 70: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027

    Figure 71: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027

    Figure 72: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027

    Figure 73: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region,

    Figure 74: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 75: Global Roadside Drugs Testing Devices Analysis, by Top Company Ranking, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved